Fischer Medical Ventures Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures has submitted a certificate to BSE and NSE from its Registrar and Share Transfer Agent, Adroit Corporate Services, under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31 December 2025. This is a routine compliance filing in which the RTA confirms that dematerialisation requests (conversion of physical shares to electronic form) have been properly processed. Along with this, the RTA shared the investor complaint status report for the quarter: only 1 complaint was received (via the SEBI SCORES platform) and it was disposed of within the same quarter. Categories such as non-receipt of share certificates, dividend warrants, and annual reports saw zero complaints. No complaints remained unresolved at the end of the quarter.
This is a routine regulatory compliance disclosure with no material business or stock price impact. The clean complaint record (1 received, 1 resolved, 0 pending) indicates healthy investor service standards.